Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Deferred Revenue (2023 - 2025)

Zhengye Biotechnology Holding has reported Current Deferred Revenue over the past 3 years, most recently at $669996.8 for Q4 2025.

  • Quarterly Current Deferred Revenue rose 23.88% to $669996.8 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $669996.8 through Dec 2025, up 23.88% year-over-year, with the annual reading at $11000.0 for FY2025, 97.69% down from the prior year.
  • Current Deferred Revenue was $669996.8 for Q4 2025 at Zhengye Biotechnology Holding, up from $140000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $669996.8 in Q4 2025 and troughed at $140000.0 in Q2 2025.
  • The 3-year median for Current Deferred Revenue is $589937.0 (2023), against an average of $497467.7.
  • Year-over-year, Current Deferred Revenue fell 15.36% in 2024 and then rose 23.88% in 2025.
  • A 3-year view of Current Deferred Revenue shows it stood at $639020.9 in 2023, then fell by 15.36% to $540853.1 in 2024, then grew by 23.88% to $669996.8 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Current Deferred Revenue are $669996.8 (Q4 2025), $140000.0 (Q2 2025), and $540853.1 (Q4 2024).